Non-injection drug use and Hepatitis C Virus: A systematic review

Roberta Scheinmann, Holly Hagan, Corina Lelutiu-Weinberger, Rebecca Stern, Don Des Jarlais, Peter L. Flom, Shiela Strauss

Research output: Contribution to journalArticle

Abstract

This systematic review examined the evidence on the prevalence of the Hepatitis C Virus (HCV) in non-injecting drug users (NIDUs) who sniff, smoke or snort drugs such as heroin, cocaine, crack or methamphetamine. The search included studies published from January 1989 to January 2006. Twenty-eight eligible studies were identified and the prevalence of HCV in these NIDU populations ranged from 2.3 to 35.3%. There was substantial variation in study focus and in the quality of the NIDU data presented in the studies. The results of our systematic review suggested that there are important gaps in the research of HCV in NIDUs. We identified a problem of study focus; much of the research did not aim to study HCV in users of non-injection drugs. Instead, NIDUs were typically included as a secondary research concern, with a principal focus on the problem of transmission of HCV in IDU populations. Despite methodological issues, HCV prevalence in this population is much higher than in a non-drug using population, even though some IDUs might have inadvertently been included in the NIDU samples. These studies point to a real problem of HCV in NIDU populations, but the causal pathway to infection remains unclear.

Original languageEnglish (US)
Pages (from-to)1-12
Number of pages12
JournalDrug and Alcohol Dependence
Volume89
Issue number1
DOIs
StatePublished - Jun 15 2007

Fingerprint

Drug Users
Viruses
Hepacivirus
contagious disease
drug use
drug
Pharmaceutical Preparations
Population
Research
Crack Cocaine
Methamphetamine
Heroin
Smoke
Infection

Keywords

  • Crack cocaine
  • Drug use
  • Epidemiology
  • HCV
  • Heroin
  • Non-injection drug use
  • Prevalence

ASJC Scopus subject areas

  • Medicine(all)
  • Behavioral Neuroscience
  • Toxicology
  • Health(social science)

Cite this

Non-injection drug use and Hepatitis C Virus : A systematic review. / Scheinmann, Roberta; Hagan, Holly; Lelutiu-Weinberger, Corina; Stern, Rebecca; Des Jarlais, Don; Flom, Peter L.; Strauss, Shiela.

In: Drug and Alcohol Dependence, Vol. 89, No. 1, 15.06.2007, p. 1-12.

Research output: Contribution to journalArticle

Scheinmann, Roberta ; Hagan, Holly ; Lelutiu-Weinberger, Corina ; Stern, Rebecca ; Des Jarlais, Don ; Flom, Peter L. ; Strauss, Shiela. / Non-injection drug use and Hepatitis C Virus : A systematic review. In: Drug and Alcohol Dependence. 2007 ; Vol. 89, No. 1. pp. 1-12.
@article{323046747fd94fb48313a1d0ff38d671,
title = "Non-injection drug use and Hepatitis C Virus: A systematic review",
abstract = "This systematic review examined the evidence on the prevalence of the Hepatitis C Virus (HCV) in non-injecting drug users (NIDUs) who sniff, smoke or snort drugs such as heroin, cocaine, crack or methamphetamine. The search included studies published from January 1989 to January 2006. Twenty-eight eligible studies were identified and the prevalence of HCV in these NIDU populations ranged from 2.3 to 35.3{\%}. There was substantial variation in study focus and in the quality of the NIDU data presented in the studies. The results of our systematic review suggested that there are important gaps in the research of HCV in NIDUs. We identified a problem of study focus; much of the research did not aim to study HCV in users of non-injection drugs. Instead, NIDUs were typically included as a secondary research concern, with a principal focus on the problem of transmission of HCV in IDU populations. Despite methodological issues, HCV prevalence in this population is much higher than in a non-drug using population, even though some IDUs might have inadvertently been included in the NIDU samples. These studies point to a real problem of HCV in NIDU populations, but the causal pathway to infection remains unclear.",
keywords = "Crack cocaine, Drug use, Epidemiology, HCV, Heroin, Non-injection drug use, Prevalence",
author = "Roberta Scheinmann and Holly Hagan and Corina Lelutiu-Weinberger and Rebecca Stern and {Des Jarlais}, Don and Flom, {Peter L.} and Shiela Strauss",
year = "2007",
month = "6",
day = "15",
doi = "10.1016/j.drugalcdep.2006.11.014",
language = "English (US)",
volume = "89",
pages = "1--12",
journal = "Drug and Alcohol Dependence",
issn = "0376-8716",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Non-injection drug use and Hepatitis C Virus

T2 - A systematic review

AU - Scheinmann, Roberta

AU - Hagan, Holly

AU - Lelutiu-Weinberger, Corina

AU - Stern, Rebecca

AU - Des Jarlais, Don

AU - Flom, Peter L.

AU - Strauss, Shiela

PY - 2007/6/15

Y1 - 2007/6/15

N2 - This systematic review examined the evidence on the prevalence of the Hepatitis C Virus (HCV) in non-injecting drug users (NIDUs) who sniff, smoke or snort drugs such as heroin, cocaine, crack or methamphetamine. The search included studies published from January 1989 to January 2006. Twenty-eight eligible studies were identified and the prevalence of HCV in these NIDU populations ranged from 2.3 to 35.3%. There was substantial variation in study focus and in the quality of the NIDU data presented in the studies. The results of our systematic review suggested that there are important gaps in the research of HCV in NIDUs. We identified a problem of study focus; much of the research did not aim to study HCV in users of non-injection drugs. Instead, NIDUs were typically included as a secondary research concern, with a principal focus on the problem of transmission of HCV in IDU populations. Despite methodological issues, HCV prevalence in this population is much higher than in a non-drug using population, even though some IDUs might have inadvertently been included in the NIDU samples. These studies point to a real problem of HCV in NIDU populations, but the causal pathway to infection remains unclear.

AB - This systematic review examined the evidence on the prevalence of the Hepatitis C Virus (HCV) in non-injecting drug users (NIDUs) who sniff, smoke or snort drugs such as heroin, cocaine, crack or methamphetamine. The search included studies published from January 1989 to January 2006. Twenty-eight eligible studies were identified and the prevalence of HCV in these NIDU populations ranged from 2.3 to 35.3%. There was substantial variation in study focus and in the quality of the NIDU data presented in the studies. The results of our systematic review suggested that there are important gaps in the research of HCV in NIDUs. We identified a problem of study focus; much of the research did not aim to study HCV in users of non-injection drugs. Instead, NIDUs were typically included as a secondary research concern, with a principal focus on the problem of transmission of HCV in IDU populations. Despite methodological issues, HCV prevalence in this population is much higher than in a non-drug using population, even though some IDUs might have inadvertently been included in the NIDU samples. These studies point to a real problem of HCV in NIDU populations, but the causal pathway to infection remains unclear.

KW - Crack cocaine

KW - Drug use

KW - Epidemiology

KW - HCV

KW - Heroin

KW - Non-injection drug use

KW - Prevalence

UR - http://www.scopus.com/inward/record.url?scp=34247156111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247156111&partnerID=8YFLogxK

U2 - 10.1016/j.drugalcdep.2006.11.014

DO - 10.1016/j.drugalcdep.2006.11.014

M3 - Article

C2 - 17174481

AN - SCOPUS:34247156111

VL - 89

SP - 1

EP - 12

JO - Drug and Alcohol Dependence

JF - Drug and Alcohol Dependence

SN - 0376-8716

IS - 1

ER -